CaRe Clinic Joins hyperCORE International to Strengthen Global Clinical Research Capabilities
TL;DR
Joining hyperCORE International gives CaRe Clinic a competitive advantage in expanding global reach and capabilities through alliance partnerships.
CaRe Clinic's community-centric recruitment strategy, state-of-the-art research centers, and strong partnerships contribute to its success in redefining medical research in Canada.
CaRe Clinic's partnership with hyperCORE International aims to pioneer breakthroughs that will benefit patients worldwide, highlighting Canada's robust clinical research ecosystem on the global stage.
CaRe Clinic's broad combination of investigators' patient databases and access to a reservoir of over 1.8 million potential patients makes it a key player in advancing clinical research.
Found this article helpful?
Share it with your network and spread the knowledge!
The strategic alliance between CaRe Clinic and hyperCORE International represents a significant advancement in global clinical research infrastructure, combining extensive patient access with international research expertise. This partnership brings together CaRe Clinic's two state-of-the-art research centers in Calgary and Red Deer with hyperCORE's established global network, creating enhanced capabilities for conducting Phase I-IV clinical trials across multiple therapeutic areas.
CaRe Clinic contributes substantial resources to the collaboration, including access to a potential patient pool exceeding 1.8 million individuals through investigator databases and affiliated clinic partnerships. This extensive reach, combined with the organization's community-centric recruitment approach, addresses one of the most persistent challenges in clinical research: participant enrollment. The clinic's proven track record includes hundreds of completed trials across diverse medical fields such as women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments.
Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the partnership's global implications, noting that it facilitates unprecedented cross-border collaboration and sharing of best practices. The alliance aims to showcase Canada's robust clinical research ecosystem while contributing to pioneering medical breakthroughs that benefit patients worldwide. This integration immediately expands hyperCORE's Canadian presence with multiple locations and multi-therapeutic offerings, strengthening the network's position across two continents and five countries with more than 120 active research sites.
Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the expanded capabilities, highlighting how the partnership adds a solid Canadian partner to their team. hyperCORE International brings decades of clinical research experience to the collaboration, with alliance partners having completed more than 7,000 studies and evaluated thousands of new drugs and treatments across over 150,000 randomized patients. The organization maintains strong commitment to research excellence, prioritizing subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention.
This collaboration signals a broader trend toward integrated, efficient, and globally connected clinical research networks that can accelerate drug development timelines. By leveraging combined strengths in patient recruitment and international research infrastructure, the partnership addresses critical bottlenecks in clinical trials while enhancing the quality and speed of medical research. The alliance positions both organizations to tackle complex research challenges more effectively, potentially leading to faster development of treatments across multiple therapeutic areas and benefiting healthcare systems globally through improved research efficiency and expanded trial accessibility.
Curated from 24-7 Press Release
